Omada Health (NASDAQ:OMDA) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Omada Health (NASDAQ:OMDA) from a hold rating to a buy rating in a research report released on Saturday.

Other equities analysts have also issued research reports about the stock. Morgan Stanley reaffirmed an “overweight” rating and set a $30.00 target price on shares of Omada Health in a research report on Monday, June 22nd. Citigroup restated an “outperform” rating on shares of Omada Health in a report on Monday, July 20th. Weiss Ratings lowered shares of Omada Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, July 13th. Evercore reiterated an “outperform” rating and issued a $20.00 target price on shares of Omada Health in a research note on Friday, May 8th. Finally, BTIG Research started coverage on Omada Health in a research note on Friday, July 17th. They set a “buy” rating and a $30.00 price target on the stock. Eleven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $25.25.

Omada Health Stock Performance

NASDAQ OMDA opened at $23.67 on Friday. The stock has a 50-day simple moving average of $20.36 and a 200 day simple moving average of $16.20. Omada Health has a twelve month low of $10.28 and a twelve month high of $26.92. The stock has a market capitalization of $1.41 billion, a PE ratio of 473.40 and a beta of 1.73.

Omada Health (NASDAQ:OMDA) last released its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. Omada Health had a return on equity of 2.67% and a net margin of 1.39%.The firm had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. As a group, equities research analysts forecast that Omada Health will post -0.01 EPS for the current fiscal year.

Insider Buying and Selling at Omada Health

In other news, CFO Steven L. Cook sold 12,337 shares of the stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $23.09, for a total value of $284,861.33. Following the completion of the transaction, the chief financial officer owned 187,209 shares in the company, valued at approximately $4,322,655.81. This represents a 6.18% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Craig Gracey sold 2,083 shares of Omada Health stock in a transaction dated Monday, June 29th. The shares were sold at an average price of $21.00, for a total transaction of $43,743.00. Following the sale, the chief accounting officer owned 858 shares in the company, valued at approximately $18,018. This trade represents a 70.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 206,406 shares of company stock valued at $4,191,483 in the last 90 days. 6.38% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Omada Health

Large investors have recently modified their holdings of the stock. Quarry LP bought a new position in shares of Omada Health during the 4th quarter worth approximately $29,000. TD Waterhouse Canada Inc. bought a new stake in Omada Health in the fourth quarter valued at $32,000. Raymond James Financial Inc. acquired a new position in Omada Health during the second quarter worth $32,000. Inlight Wealth Management LLC acquired a new position in Omada Health during the fourth quarter worth $45,000. Finally, Versant Capital Management Inc lifted its holdings in shares of Omada Health by 319.3% during the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after acquiring an additional 2,283 shares during the period.

Key Stories Impacting Omada Health

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Second-quarter results exceeded expectations: Omada reported revenue of approximately $87.8 million, above the $80.9 million consensus estimate. Adjusted earnings per share also surpassed forecasts, with reports citing approximately $0.08 to $0.15 per share versus expectations ranging from a loss of $0.02 to $0.05. Results improved from a year-earlier loss. Omada Health quarterly earnings report
• Positive Sentiment: Growth remained strong: Second-quarter revenue rose 43% year over year, while total members increased 45%. Omada also achieved a record quarterly gross margin, supporting the case that operating leverage and scale are improving. Omada Health second-quarter results
• Positive Sentiment: 2026 revenue guidance was raised or reaffirmed above consensus: Omada projected full-year revenue of $334 million to $340 million, exceeding the approximately $327.2 million analyst estimate. The outlook signals continued demand for its virtual chronic-care platform. Omada Health revenue outlook
• Neutral Sentiment: Leadership transition announced: Co-founder and CEO Sean Duffy will become executive chair on January 1, 2027, while President Wei-Li Shao is scheduled to become CEO. The planned, internal succession may provide continuity, although investors could monitor execution under the new leadership. Omada Health CEO transition
• Negative Sentiment: CEO stock sale adds a modest overhang: Duffy sold 12,944 shares for approximately $264,000, reducing his direct position by 3.05%. The sale occurred before the earnings release and may be routine, but insider selling can temper sentiment.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.